PE Weekly: Healthcare Dealmaking Continues its Rebound
Transactions across hospice care, pharmacy care management, and other healthcare niches signal a return to dealmaking in the space
Key Considerations in Healthcare Technology M&A
As some healthcare investors pivot towards healthcare tech, certain sector-specific issues must be addressed
How Mesirow’s Doug Brookman Navigates DealMAX—and Why His Playbook Works
The 2026 conference committee chair reveals the networking strategies, event upgrades, and hidden gems that make ACG’s DealMAX the most productive middle-market M&A event of the year
Why Manufacturing Execs Are Bullish on 2026
Bryan Wright of Forvis Mazars offers insights into manufacturing M&A
PE Weekly: Carve-outs, Take-Privates Drive M&A Into 2026
As 2025 comes to a close, middle-market dealmakers keep M&A volume up with carve-out deals and take-private transactions
Why More Sellers Are Using Quality of Earnings Reports for M&A Deals
New data from GF Data reveals sell-side QoE draw higher valuation multiples
Nominate a 2026 ‘M&A Business Development Professional to Watch’
Now through Jan. 16, nominate an M&A Business Development Pro to Watch across private equity, investment banking, corporate development, and our newest category, lending
Q3 2025: Valuations Up, Deal Volume Down
Forvis Mazar's Scott Linch and GF Data's Bob Dunn are back with a Q3 2025 update
PE Weekly: Home Maintenance, Repair Businesses Entice Investors
Plus, commercial services like paving drive M&A activity, too
Dealmakers Eye a Rebound: ACG Chicago Panelists Discuss M&A Outlook and Talent Trends
Insights from ACG Chicago’s Midwest Capital Connection
